Elutia to Participate in Upcoming Investor Conferences
Rhea-AI Summary
Elutia (Nasdaq: ELUT), a pioneer in drug-eluting biomatrix technologies, has announced its participation in two upcoming investor conferences in April 2025.
The company's leadership team, including Dr. Randy Mills (President and CEO) and Matt Ferguson (CFO), will attend:
- The LD Micro 15th Annual Invitational in New York on April 10, 2025, presenting at 12:30 p.m. ET
- The Planet Microcap Showcase in Las Vegas on April 23, 2025, presenting at 4:00 p.m. ET
Both events will feature company presentations and one-on-one meetings with investors. Institutional investors can schedule meetings through conference representatives or by contacting IR@elutia.com.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, ELUT gained 5.05%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
SILVER SPRING, Md., April 03, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, and Matt Ferguson, Chief Financial Officer, will participate in the following upcoming investor conferences:
LD Micro 15th Annual Invitational – New York, NY
Format: Presentation and 1x1 Meetings
Presentation Date and Time: Thursday, April 10, 2025, 12:30 p.m. ET (9:30 a.m. PT)
Webcast: Click Here
Planet Microcap Showcase – Las Vegas, NV
Format: Presentation and 1x1 Meetings
Presentation Date and Time: Wednesday, April 23, 2025, 4:00 p.m. ET (1:00 p.m. PT)
Webcast: Click Here
Elutia management will also participate in 1x1 investor meetings. Institutional investors interested in scheduling a meeting may contact an LD Micro or Planet Microcap representative or email IR@elutia.com.
About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com
This press release was published by a CLEAR® Verified individual.
FAQ
When is Elutia (ELUT) presenting at the LD Micro Invitational 2025?
What investor conferences is Elutia (ELUT) attending in April 2025?
How can investors schedule meetings with Elutia (ELUT) management at the upcoming conferences?
When is Elutia's (ELUT) presentation at the Planet Microcap Showcase 2025?
Which Elutia (ELUT) executives are participating in the April 2025 investor conferences?
